Parbraze 150mg Tablet

Parbraze 150mg Tablet is a PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitor, a class of cancer medication. It contains olaparib as the active ingredient. It is indicated for the treatment of ovarian, breast, pancreatic, and prostate cancers. The medication may be administered as monotherapy or in combination with other anticancer agents. Olaparib should not be used if you have an allergy to the active ingredient or other components of the tablet. Contact your doctor immediately if you develop breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will perform blood tests before treatment initiation and every month during therapy, as this medicine may decrease red blood cell, white blood cell, and platelet counts. Inform your healthcare provider before starting treatment if you have a history of lung, liver, heart, or kidney disease. This medication is not recommended during pregnancy as it may cause fetal harm and miscarriage. Women of reproductive potential should obtain a pregnancy test before commencing therapy. Continued use of contraception for at least six months following completion of treatment is advisable. Breastfeeding is not recommended during treatment as it is not established whether Parbraze 150mg Tablet is excreted in breast milk. Male patients should not donate sperm for at least 3 months after treatment completion. Inform your doctor of all medications you are taking, including prescription drugs, over-the-counter medicines, vitamins, and supplements.

Parbraze 150mg Tablet is used to treat, Maintenance therapy for various types of Advanced ovarian cancer Treatment of early and metastatic Breast cancer Treatment of Prostate cancer Metastatic Pancreatic cancer

Parbraze 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Parbraze 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.

The medicine will be prescribed to you by a healthcare professional in a hospital setting. Parbraze 150mg Tablet is to be taken with or without food, as directed by your healthcare provider. The dose will be decided by your healthcare professional based on your conditions. Avoid crushing, opening, or dissolving the tablet and swallow it whole with a glass of water. Take the Parbraze 150mg Tablet at the same time every day.

Side effects are unwanted symptoms caused by medicines. Although all drugs cause side effects, not everyone experiences them. Common: Shortness of breath Nausea Vomiting Fatigue Dyspepsia Loss of appetite Dizziness Diarrhoea Headache Serious: Neutropenia Acute myeloid leukemia Leukopenia Thrombocytopenia Lung problems

Parbraze 150mg Tablet can lower blood cell counts. Thus, it's best to get blood tests done at regular intervals. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside. Parbraze 150mg Tablet should not be stopped without first talking to your doctor. When using this medication, stay away from grapefruit juice as it may raise your blood levels of the drug. It is recommended to inform your doctor about other anticancer drugs you have been taking. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhoea and other gastrointestinal disorders. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping Parbraze 150mg Tablet. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately. With proper monitoring and management, Parbraze 150mg Tablet can be an effective treatment option for certain types of cancer.